UBS Group AG - KINTARA THERAPEUTICS INC ownership

KINTARA THERAPEUTICS INC's ticker is and the CUSIP is 49720K200. A total of 11 filers reported holding KINTARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KINTARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$262
-96.5%
65
-97.0%
0.00%
Q1 2023$7,548
-22.0%
2,139
+52.4%
0.00%
Q4 2022$9,6741,4040.00%
Other shareholders
KINTARA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nantahala Capital Management 22,619$91,3810.01%
VANGUARD GROUP INC 12,455$50,3180.00%
OSAIC HOLDINGS, INC. 949$3,8330.00%
BANK OF AMERICA CORP /DE/ 200$8080.00%
WELLS FARGO & COMPANY/MN 12$480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,923$56,4210.00%
STATE STREET CORP 10,721$43,4200.00%
MORGAN STANLEY 3,346$13,5180.00%
ACADIAN ASSET MANAGEMENT LLC 6,480$250.00%
View complete list of KINTARA THERAPEUTICS INC shareholders